Kodo Lifescience Private Limited

Vapi/Valsad, India
Plasmid DNA Lentiviral Cell & Gene Therapy Raw Materials
Program data pending ClinicalTrials.gov matching
57.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Kodo Lifescience Private Limited

Signal Score
57.5/100
Quality Compliance
Assessment pending
Headquarters
Vapi/Valsad, India
Modalities
Plasmid DNA, Lentiviral, Cell & Gene Therapy Raw Materials
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Kodo Lifescience Private Limited

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesPlasmid DNA, Lentiviral, Cell & Gene Therapy Raw Materials
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 55.0
Manufacturing site information being gathered
Modalities: Plasmid DNA, Lentiviral, Cell & Gene Therapy Raw Materials
Capacity assessment: 55.0/100
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Manufacturing site information being gathered
Modalities: Plasmid DNA, Lentiviral, Cell & Gene Therapy Raw Materials
Capacity assessment: 55.0/100

Frequently Asked Questions About Kodo Lifescience Private Limited

What is Kodo Lifescience Private Limited's CDMO Signal Score?
Kodo Lifescience Private Limited has a Signal Score of 58/100, based on quality, operations, financial stability, and capacity data.
Evaluating Kodo Lifescience Private Limited for a manufacturing program?
Use the free AI matchmaker to compare Kodo Lifescience Private Limited against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Plasmid DNA CDMOs → Lentiviral CDMOs → Cell & Gene Therapy Raw Materials CDMOs →

Similar CDMOs

Kodo LifeScience Pvt. Ltd.
Valsad, Gujarat, India
Plasmid DNA, Lentiviral Vector, Cell & Gene Therapy Raw Materials, CAR-T
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 83.1
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid
Oxford Biomedica
Oxford, United Kingdom
Signal Score: 77.1
Lentiviral, AAV, Plasmid DNA
Andelyn Biosciences
Columbus, OH
Signal Score: 63.0
AAV, Lentiviral, Plasmid DNA
CoJourney Inc.
Horsham, PA (US HQ); Hangzhou, China (primary GMP manufacturing)
Signal Score: 60.0
Plasmid DNA, AAV, Adenoviral, Lentiviral, Retroviral, mRNA, sgRNA, Exosome